Bio

Peter Strothman has spent his career investing in the healthcare industry. He specializes in life sciences, specialty pharmaceutical products and services, and general healthcare products and services. Peter has built a premier group of life sciences companies and established an innovative corporate partnership program that supports global organizations with developing next-generation pharmaceutical and medical device products. Prior to Water Street, Peter was a principal with JLL Partners, where he focused on healthcare investments. He began his career in the Global Mergers and Acquisitions group of Lehman Brothers. Peter currently serves as a director of Allucent, Catalyx, EVERSANA, Discovery Life Sciences, Capstone Development Solutions, Long Grove Pharmaceuticals, Solvias, THREAD and Viant. He is a former director of AAIPharma Services, Bioclinica, Custopharm, and OraPharma. Peter received a bachelor’s degree in economics from Harvard University.